PMGC Holdings Inc. (NASDAQ:ELAB) Sees Large Growth in Short Interest

PMGC Holdings Inc. (NASDAQ:ELAB) saw a significant growth in short interest in July. As of July 15th, there was short interest totaling 809,201 shares, a growth of 144.4% from the June 30th total of 331,075 shares. Based on an average trading volume of 10,484,044 shares, the short-interest ratio is currently 0.1 days. Currently, 69.8% of the shares of the company are short sold.

PMGC Stock Up 2.2%

ELAB opened at $0.92 on Tuesday. The business has a 50 day moving average price of $1.37 and a two-hundred day moving average price of $6.23. The company has a quick ratio of 1.43, a current ratio of 1.45 and a debt-to-equity ratio of 0.03. The company has a market cap of $1.07 million, a PE ratio of -0.01 and a beta of -0.23. PMGC has a 52 week low of $0.84 and a 52 week high of $309.12.

PMGC (NASDAQ:ELAB) last released its earnings results on Thursday, May 14th. The company reported ($11.22) earnings per share (EPS) for the quarter. The firm had revenue of $0.68 million during the quarter.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of PMGC in a report on Friday, June 26th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has an average rating of “Sell”.

PMGC Company Profile

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.